Incyte today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 ...

Sunrun's balance sheet strength is evident with $709M unrestricted cash and six consecutive quarters of positive cash flow.

Fraunhofer IIS is developing an affordable solution for continuous infrastructure monitoring by adapting radar sensors originally designed for the automotive sector. In response to growing concerns ...

Fraunhofer researchers are developing a portable gas chromatography sensor system that enables rapid, on-site detection of counterfeit foods and contaminated materials without the need for laboratory ...